These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 11790496)

  • 1. Application of TPX polymer membranes for the controlled release of triprolidine.
    Shin SC; Yoon MK
    Int J Pharm; 2002 Jan; 232(1-2):131-7. PubMed ID: 11790496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal delivery of triprolidine using TPX polymer membrane.
    Shin SC; Kim J; Yoon MK; Oh IJ; Choi JS
    Int J Pharm; 2002 Mar; 235(1-2):141-7. PubMed ID: 11879749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Sep; 54(2):201-6. PubMed ID: 12191692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of triprolidine from the transdermal TPX matrix system in rabbits.
    Shin SC; Choi JS
    Int J Pharm; 2002 Mar; 234(1-2):67-73. PubMed ID: 11839438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihistamine effects of triprolidine from the transdermal administration of the TPX matrix in rats.
    Shin SC; Choi JS
    Arch Pharm Res; 2005 Jan; 28(1):111-4. PubMed ID: 15742818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix.
    Shin SC; Lee HJ
    Eur J Pharm Biopharm; 2002 Nov; 54(3):325-8. PubMed ID: 12445563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer.
    Cho CW; Kim SJ; Yang KH; Song JH; Jeong HJ; Shin SC
    Drug Deliv; 2008 Sep; 15(7):423-8. PubMed ID: 18712619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats.
    Shin SC; Choi JS
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):14-9. PubMed ID: 16005195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of asymmetric TPX membranes to transdermal delivery of nitroglycerin.
    Wang DM; Lin FC; Chen LY; Lai JY
    J Control Release; 1998 Jan; 50(1-3):187-95. PubMed ID: 9685885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of pranoprofen from the ethylene-vinyl acetate matrix using plasticizer.
    Cho CW; Choi JS; Shin SC
    Drug Dev Ind Pharm; 2007 Jul; 33(7):747-53. PubMed ID: 17654023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release of atenolol from the ethylene-vinyl acetate matrix.
    Kim J; Shin SC
    Int J Pharm; 2004 Apr; 273(1-2):23-7. PubMed ID: 15010126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled release of furosemide from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Shin SC
    Int J Pharm; 2005 Aug; 299(1-2):127-33. PubMed ID: 15967605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release characteristics of quinupramine from the ethylene-vinyl acetate matrix.
    Kim J; Kim WJ; Kim SJ; Cho CW; Shin SC
    Int J Pharm; 2006 Jun; 315(1-2):134-9. PubMed ID: 16644151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Controlled Transdermal Delivery of Mexazolam Using Ethylene-vinyl Acetate.
    Weon Cho C; Chul Shin S
    Iran J Pharm Res; 2012; 11(1):3-12. PubMed ID: 25317180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility-modulated asymmetric membrane tablets of triprolidine hydrochloride: statistical optimization and evaluation.
    Dev R; Kumar A; Pathak K
    AAPS PharmSciTech; 2012 Mar; 13(1):174-83. PubMed ID: 22183255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of oral and transdermal triprolidine.
    Miles MV; Balasubramanian R; Pittman AW; Grossman SH; Pappa KA; Smith MF; Wargin WA; Findlay JW; Poust RI; Frosolono MF
    J Clin Pharmacol; 1990 Jun; 30(6):572-5. PubMed ID: 2355108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: role of passive diffusion in the direct nose-to-brain uptake of small molecules.
    Kandimalla KK; Donovan MD
    Int J Pharm; 2005 Sep; 302(1-2):133-44. PubMed ID: 16105724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Eudragit RS to thermo-sensitive drug delivery systems: II. Effect of temperature on drug permeability through membrane consisting of Eudragit RS/PEG 400 blend polymers.
    Fujimori J; Yoshihashi Y; Yonemochi E; Terada K
    J Control Release; 2005 Jan; 102(1):49-57. PubMed ID: 15653133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of thermal and rheological properties of zidovudine, lamivudine and plasticizer blends with ethyl cellulose to assess their suitability for hot melt extrusion.
    Maru SM; de Matas M; Kelly A; Paradkar A
    Eur J Pharm Sci; 2011 Nov; 44(4):471-8. PubMed ID: 21925600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.